LifeVantage Corporation (LFVN)
- Previous Close
6.66 - Open
6.64 - Bid --
- Ask 6.93 x 100
- Day's Range
6.64 - 6.99 - 52 Week Range
3.04 - 8.69 - Volume
88,017 - Avg. Volume
35,969 - Market Cap (intraday)
86.219M - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
27.92 - EPS (TTM)
0.24 - Earnings Date May 2, 2024
- Forward Dividend & Yield 0.14 (2.10%)
- Ex-Dividend Date Feb 29, 2024
- 1y Target Est
--
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
www.lifevantage.comRecent News: LFVN
Performance Overview: LFVN
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LFVN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LFVN
Valuation Measures
Market Cap
85.70M
Enterprise Value
82.15M
Trailing P/E
28.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.40
Price/Book (mrq)
3.14
Enterprise Value/Revenue
0.39
Enterprise Value/EBITDA
11.19
Financial Highlights
Profitability and Income Statement
Profit Margin
1.40%
Return on Assets (ttm)
3.92%
Return on Equity (ttm)
10.00%
Revenue (ttm)
210.95M
Net Income Avi to Common (ttm)
2.96M
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
17.33M
Total Debt/Equity (mrq)
50.46%
Levered Free Cash Flow (ttm)
13.97M
Research Analysis: LFVN
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell